See All Slides - tctmd.com

Slides

Presentation TCT 2012

Case 2: Left Main Disease Plus Triple-Vessel Disease and Syntax Score <32: PCI vs. CABG

Presenter: Mauro Carlino

October 22, 2012

Presentation TCT 2012

Case Presentation(2)

Presenter: Bernhard Witzenbichler

October 22, 2012

Presentation TCT 2012

The Clinical Business Model for CTO PCI in the United States: Do Procedure Time, Reimbursement, and Costs Preclude Development of CTO PCI Programs?

Presenter: Dimitri Karmpaliotis

October 22, 2012

Presentation TCT 2012

TCT-108: Performance and Safety of the TRUE Dilatation Balloon Valvuloplasty Catheter for Aortic Balloon Valvuloplasty in Patients Undergoing TAVR

Presenter: Felix Woitek

October 22, 2012

Presentation TCT 2012

Contemporary Surgical Outcomes in Normal and High-Risk Patients with Aortic Stenosis

Presenter: Vinod Thourani

October 22, 2012

Presentation TCT 2012

Introduction(14)

Presenter: Sigmund Silber

October 22, 2012

Presentation TCT 2012

Phase II and III Clinical Trials: Off and Running!

Presenter: Amit Patel

October 22, 2012

Presentation TCT 2012

Non-Left Main Bifurcation Stenting: Highlights from the Last 12 Months

Presenter: Nick Curzen

October 22, 2012

Presentation TCT 2012

Should Interventionalists Even Assess Post-PCI Biomarkers (CKMB, Troponins, or ECGs)?

Presenter: Allan Jaffe

October 22, 2012

Presentation TCT 2012

Magnetic Resonance Imaging Guidance During Interventional Cardiovascular Procedures

Presenter: Robert Lederman

October 22, 2012

Advertisement

Slides

Case 2: Left Main Disease Plus Triple-Vessel Disease and Syntax Score <32: PCI vs. CABG

Case Presentation(2)

The Clinical Business Model for CTO PCI in the United States: Do Procedure Time, Reimbursement, and Costs Preclude Development of CTO PCI Programs?

TCT-108: Performance and Safety of the TRUE Dilatation Balloon Valvuloplasty Catheter for Aortic Balloon Valvuloplasty in Patients Undergoing TAVR

Contemporary Surgical Outcomes in Normal and High-Risk Patients with Aortic Stenosis

Introduction(14)

Phase II and III Clinical Trials: Off and Running!

Non-Left Main Bifurcation Stenting: Highlights from the Last 12 Months

Should Interventionalists Even Assess Post-PCI Biomarkers (CKMB, Troponins, or ECGs)?

Magnetic Resonance Imaging Guidance During Interventional Cardiovascular Procedures

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content